Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.516NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.526ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.526ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.526ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.526NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.279ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.279ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.279ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.279NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AE.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.51ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.51ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.51NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BA.2.3.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XATORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XATENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XATENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XATNUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.24ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.24ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.24ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.24NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.11ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.11ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.11ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.11NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-802.098France
BA.2.3.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BA.2.3.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.85ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.85ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.85ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.85NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.65ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.65ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.65ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.65NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.5.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.5.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BG.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BG.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BG.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BG.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.61ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used